Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The design of a vaccine against Leishmaniasis

07.05.2008
The parasitology team at the “Severo Ochoa” Molecular biology centre (CSIC-UAM) has focused its research efforts on the search for a vaccine capable of activating immunity against the parasite that causes leishmaniasis.

There is evidence that proves the feasibility of such an effective vaccine design to prevent leishmaniasis. It is based on first identifying the compounds that the parasite uses to cause the pathology, isolating them, and finally introducing those compounds into the body in a safe manner, giving the immune system a chance to be alert against a possible infection.

Leishmaniasis is a disease caused by a protozoan intracellular parasite of the genus Leishmania that exhibits diverse symptoms and pathologies. These parasites are transmitted by a dipterous insect know as a sand fly (Phlebotomus), that acts as a vector for the disease and its genus differs depending on the geographical area. Human leishmaniasis is widely distributed around the globe and according to data from the WHO there are currently around 12 million people infected and 350 million people living under the threat of the disease in 88 different countries, mainly in tropical and subtropical regions.

In Spain, canine leishmaniasis constitutes a huge problem with 50% of infected dogs developing the pathology. In most cases it ends with the death of the animal, mainly because treatments are not efficient and have highly toxic side effects. Therefore, the house dog is considered the main hide-out for Leishmania infantum in the mediterranean area, playing a key role in the transmission of the parasite into humans through the sand fly. It should also be pointed out that the cases of leishmaniasis in patients suffering from advanced stages of AIDS with weakened immune systems is increasing. And although these cases are not as frequent, there are recently described cases of Leishmaniasis in cats and some horse species in many Mediterranean as well as South American countries.

Among the determining factors for the control of the disease, the virulence of the species of leishmania involved and the genetic predisposition of the host are crucial. Based on the symptoms of the disease, leishmania has been classified in to 4 different types: cutaneous, diffuse cutaneous, mucocutaneous and visceral. Many of the compounds of leishmania are invisible to the immune system, which allows the parasite to avoid our antimicrobial defences and establish an infection. Later, when the parasite starts to disseminate through the organism, other compounds (pathoantigens) are visible to the immune system and are vital for understanding the pathology.

In this context, the work carried out at the Molecular biology research centre Severo Ochoa (CSIC-UAM) by researchers from the parasitology group, formed among others by Doctors Javier Carrión and Carlos Alonso, has been focused on Histones, (proteins responsible for the packaging of DNA). As their latest published work (february edition of Vaccine) states: histones are one of the most important compounds that the parasite uses to define its degree of virulence. Through the isolation of the compounds and using different methodologies available in the molecular parasitology scientific field these researchers have developed immunization strategies that offer an outlook of a bright future in which a vaccine against leishmaniasis is a reality.

Oficina de Cultura Científica | alfa
Further information:
http://dx.doi.org/10.1016/j.vaccine.2007.12.051
http://www.uam.es

More articles from Health and Medicine:

nachricht Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>